why can’t i think clearly walk straight be happy? luigi ferrucci, md, phd
DESCRIPTION
Why Can’t I Think Clearly Walk Straight Be Happy? Luigi Ferrucci, MD, PhD Longitudinal Studies Section Clinical Research Branch National Institute of Aging. Physical Function. Cognition. ?. Mood. Walking. Homeostatic Equilibrium (Biological Housekeeping Mechanisms). Physical - PowerPoint PPT PresentationTRANSCRIPT
Why Can’t I
Think ClearlyWalk Straight
Be Happy?
Luigi Ferrucci, MD, PhDLongitudinal Studies Section
Clinical Research Branch
National Institute of Aging
Walking
PhysicalFunction
Mood Cognition
HomeostaticEquilibrium
(Biological Housekeeping Mechanisms)
Specific Interactive MechanismsIncluding 1. Underlying Physiological Mechanisms2. “Use or Lose” Mechanisms”3. Changes in Behavioral and Social Constraints
Walking
A Bioenergetic
HYPOTHESIS1. The dysregulation of one or more elements of the network of mechanisms that maintain a stable homeostasis have negative effects on physical function, cognition and mood;
2. Such dysregulation may trigger a contro-regulatory response aimed at slowing down the human machine (principle of Maximum Efficiency). As a side effect, these events trigger a vicious cycle that leads to accelerated functional decline.
Walking
The Homeostatic Network in the BLSA
CNS
PNS
Muscles
Bone, Joints
Energy
Feedback
Insul., Ghrelin, Leptin, Adiponectin, Resistin, IGF-1, Testosterone, Estradiol, DHEAs, Cortisol, Thyroid, PTH
PCR, IL-6, sIL-6R, gp130, TNF-α, TNFr1, TNFr2, IL-18, IL-15, Homocysteine
Heart Rate Variability
Carbonylated Proteins
Food Intake, VitD,VitB12, Folate, VitE,Albumine.
Self-ReportAccelerometer
Hormones
Inflammation
Autonomic
Nutrition
Phys Activity
Ox Stress
Mobility DomainsHomeostatic Network
Mobility
Outcome
Inflammation
Walking
-1
-0.5
0
0.5
1
1.5
IL-6
IL-6r
IL-1ra
IL-18
-1.5
-1
-0.5
0
0.5
1
CRP
Fibrinogen
-1.5
-1
-0.5
0
0.5
1
CRP
Fibrinogen
-1
-0.5
0
0.5
1
1.5
IL-6
IL-6r
IL-1ra
IL-18
20-39 40-49 50-64 65-74 75-84 85+20-39 40-49 50-64 65-74 75-84 85+
n o
f S
D f
rom
th
e se
x-sp
ecif
ic m
ean
Age Groups Age Groups
Men Women
Men Women
n o
f S
D f
rom
th
e se
x-sp
ecif
ic m
ean
The Mild Pro-Inflammatory State of Aging
Ferrucci L et al. Blood. 2005;105:2294-9.
Walking Ferrucci et al. JAGS 1999;47: 639-44
0
0.2
0.4
0.6
0.8
1.0
-0.5 0 0.5 1 1.5 2 2.5 3
Ln (IL-6)
Pro
babi
lity
ofM
obili
ty D
isab
ility
2.5 pg/ml
Adjustedprobability
95% CI
95% CI
Interleukin-6 Serum Levels Predict Incident DisabilityA Case Cohort Study Nested in the EPESE
Walking
Walking Speed
0 1 2 3
Follow-up (yrs)
0.4
0.5
0.6
0.7
Wa
lkin
g S
pe
ed
on
a 4
-m C
ou
rse
(m
/se
c)
Ferrucci L et al. J Am Geriatr Soc 2002; 50: 1947-54
Walking Speed Adjustingfor Hip Flexor Strength
0 1 2 3
Follow-up (yrs)
0.4
0.5
0.6
0.7
Wa
lkin
g S
pe
ed
on
a 4
-m C
ou
rse
(m
/se
c)
Inflammation, Muscle Strength, and Physical Performance
The Women’s Health and Aging Study
Walking
IKKγIKKβ
RelA (p65)NF-κB1(p50)
IKKα
IkB
Nucleus
Virus Growth FactorsMitogens
InflammatoryCytokines
BacterialProducts
StressSignals
LPS
P P u
Ubiquiti
nation
u
IkBProteasome-Degradation
RelA (p65)NF-κB1(p50)
Inflammation(Chemokines, Cytokines, Immune Receptors, Adhesion Molecules)
SynthesisIkB
ImmortalityTelomerase expression Cell Survival and Cell Death
Antiapoptotic (i.e. Bcl-xl, hs-20) and pro-apoptotic gene expression (i.e. Fas)
AngiogenesisRegulation of VEGF, TNF, IL-1
Cell ProliferationCyclin D1, c-myc
Walking
GA
PD
H r
elat
ive
un
its
in
ten
sit
y
C 2h 4h
0
2
4
6
8
10
12P65/Rel A (Western Blot)
Nuclear p65/RelA
Inte
nsi
ty
**
* p<0.01 compared non-stimulated
C 2h 4h0
1
2
3
4
5
6
P65/Rel A (Western Blot)
P=0.06
-0.092 ± 0.021 Age*Time 4h
-0.035 ± 0.019 Age*Time 2h
8.726 ± 1.325 Time 4h
4.072 ± 1.250 Time 2h
0.032 ± 0.008Age
Age < 60 years
Age ≥ 60 years
<.0001
0.0697
<.0001
0.0011
<.0001Variable b ± S.E. P-value
Age and NF-κB Activation
Thinking
Buntix, 1996
Devanand, 1996
Henderson, 1997
Chen, 1999
Palsson, 1999
Geerlings, 2000
Summary estimate
.05Risk (Odds) Ratio and 95% Confidence Interval
.01 1.0.5 5.0
"It would be so nice if something made sense for a change."(Alice’s Adventures in Wonderland; July 4, 1865 - Charles L. Dodgson)